Innate lymphoid cells (ILCs) are a heterogeneous population of lymphocytes that lack antigen-specific receptors. ILCs respond to soluble mediators released into the tissue microenvironment when homeostasis is perturbed by pathogens or allergens (Artis and Spits, 2015; Diefenbach et al., 2014; Eberl et al., 2015; Rankin et al., 2013) . On receiving danger signals, ILCs produce cytokines and chemokines that provide a frontline defense against infections, contribute to tissue repair, and regulate adaptive immunity. Based on cytokine production, ILCs are divided into three populations: (1) ILC1s, which produce interferon-gamma (IFN-g), (2) ILC2s, which produce type 2 cytokines, and (3) ILC3s, which produce interleukin-22 (IL-22) and/or IL-17. ILC distribution is widespread in tissues but is of low abundance in blood (Gasteiger et al., 2015) . ILC1s share many properties with conventional natural killer (cNK) cells, including IFN-g production, but have distinct cytolytic capacities and, unlike cNKs, do not recirculate in blood. ILC categories functionally mirror those for T helper (Th) subsets, with ILC1s resembling Th1 cells, ILC2s resembling Th2s, and ILC3s resembling Th17s. . The similarities indicate that functional modules converging on cytokine production evolved to enable innate and adaptive arms of the immune response with shared core programs under the control of distinct activation pathways and temporal kinetics, providing the functional flexibility required to face nearly any pathogen.
INTRODUCTION
Innate lymphoid cells (ILCs) are a heterogeneous population of lymphocytes that lack antigen-specific receptors. ILCs respond to soluble mediators released into the tissue microenvironment when homeostasis is perturbed by pathogens or allergens (Artis and Spits, 2015; Diefenbach et al., 2014; Eberl et al., 2015; Rankin et al., 2013) . On receiving danger signals, ILCs produce cytokines and chemokines that provide a frontline defense against infections, contribute to tissue repair, and regulate adaptive immunity. Based on cytokine production, ILCs are divided into three populations: (1) ILC1s, which produce interferon-gamma (IFN-g), (2) ILC2s, which produce type 2 cytokines, and (3) ILC3s, which produce interleukin-22 (IL-22) and/or IL-17.
ILC distribution is widespread in tissues but is of low abundance in blood (Gasteiger et al., 2015) . ILC1s share many properties with conventional natural killer (cNK) cells, including IFN-g production, but have distinct cytolytic capacities and, unlike cNKs, do not recirculate in blood. ILC categories functionally mirror those for T helper (Th) subsets, with ILC1s resembling Th1 cells, ILC2s resembling Th2s, and ILC3s resembling Th17s. . The similarities indicate that functional modules converging on cytokine production evolved to enable innate and adaptive arms of the immune response with shared core programs under the control of distinct activation pathways and temporal kinetics, providing the functional flexibility required to face nearly any pathogen.
In addition to signature cytokines, ILC lineages have been defined in mouse by transcriptome analyses and ontogenic relationships (Klose et al., 2014; Rankin et al., 2016; Robinette et al., 2015) . ILC1 and cNK cells share many transcripts, with a major distinction being expression of EOMES in cNKs (Daussy et al., 2014; Klose et al., 2014) . Lineage tracing in mice has clarified developmental relationships among ILC subsets. Similar to T cells, all ILC subsets and cNKs originate from common lymphoid progenitors (CLPs), which give rise to common innate lymphoid progenitors (CILPs) with restricted potential to generate ILCs and cNKs . CILPs differentiate into progenitors with more restricted potential, such as the NK progenitor (NKP), the common helper lymphoid progenitor (CHILP), and the innate lymphoid cell progenitor (iLCP), which together give rise to all ILCs (Constantinides et al., 2014; Klose et al., 2014; Xu et al., 2015) .
Specification of ILC lineages from precursors depends on distinct transcription factors (TFs), some of which also mediate polarization of Th cells. RORgT and the aryl hydrocarbon receptor (AHR) coordinate both ILC3 and Th17 differentiation (Diefenbach et al., 2014; Quintana, 2013; Stockinger et al., 2011; Wang et al., 2015) . TBX21 (T-BET) is necessary for development of Th1, ILC1, and cNK cells, and EOMES is uniquely required for cNK differentiation (Diefenbach et al., 2014; Eberl et al., 2015) . GATA3 specifies ILC2 and Th2 lineages, but is also required early in ILC lineage specification and later for ILC3 homeostasis (De Obaldia and Bhandoola, 2015; Diefenbach et al., 2014; Tindemans et al., 2014) . Additional TFs, such as ID2, act at the CHILP stage, driving ILC development by antagonizing T-lineage-specifying functions of E2A family TFs (Klose et al., 2014) .
Compared with mouse subsets, human ILC subsets are under-characterized. Human ILC3s are primarily defined by their ability to produce IL-22 in response to IL-23 (Cella et al., 2010) . Human ILC3s also produce GM-CSF and IL-26, as well as two other soluble mediators, LIF and BAFF, which are not (legend continued on next page) substantially expressed by Th17 cells or mouse ILC3s (Cella et al., 2010) . Although developmental data are limited, tonsillar ILC3s express RORC, plus AHR, and appear to derive from a CD34 + c-Kit + RORC + hematopoietic progenitor (Montaldo et al., 2014) . However, assignment of human ILC3s to a distinct lineage remains controversial due to reports that they are intermediates in a linear differentiation pathway for cNKs (Hughes et al., 2014) . ILC3s also exhibit some functional plasticity under certain conditions in vitro that stimulate IFN-g production (Cella et al., 2010) .
Human ILC1s include a major subset in mucosal epithelium, intraepithelial ILC1s (iILC1s), which produce IFN-g in response to IL-15 and IL-12 (Fuchs et al., 2013) . Unlike cNKs, iILC1s are unresponsive to IL-18, have limited cytolytic capacity, and express markers of intraepithelial residency, such as CD103, CD160, CD49a, and CD101. Like Th1s, most tonsillar iILC1s express T-BET and low amounts of EOMES. Fate mapping in mouse has shown that iILC1s are a distinct lineage from cNKs (Constantinides et al., 2014 (Constantinides et al., , 2015 . Although a second ILC1 subset has been reported in human (Bernink et al., 2013) , these IFNg-producing cells are found at very low frequencies in mucosalassociated lymphoid tissues. Similar to mouse, human ILC2s express GATA3 and produce IL-5 and IL-13 (Mjö sberg et al., 2011) , but these cells are found mostly in inflamed tissues from subjects with allergies.
Despite functional and ontogenic similarities, differences exist between ILC and Th counterparts, especially their dependence on pathogen-derived antigens. Th priming requires signals from TCR and co-stimulatory receptors, which drive expansion, differentiation, and cytokine expression. ILC effector responses solely depend on cytokine microenvironments, endowing them with more rapid response profiles. Distinctions in cytokine expression also exist between human ILC-Th counterparts-Th17s produce IL-17 and IL-22, and ILC3s secrete only the latter.
A comprehensive analysis of gene expression and regulatory pathways for human ILC-Th subsets is lacking. In this regard, epigenetic landscapes, which reflect patterns of regulatory element activity, provide rich information about lineage and functional relationships (Gosselin et al., 2014; Kanno et al., 2012; Koues et al., 2015; Mercer et al., 2011; Mukasa et al., 2010) . We now report regulatory circuitries for gene expression programs in human ILC3, iILC1, Th17, and Th1 cells from tonsil, a mucosal-associated lymphoid tissue. Based on their regulatory logic and transcriptomes, we find that ILC3s indeed constitute a unique lineage in humans. ILCs and Th cells employ a combination of overlapping and divergent enhancers to express shared genes, while activating signature expression programs that mediate unique functions of innate and adaptive immunity. Our epigenome-centric approach identified a collection of ILC super-enhancers that regulate the expression of cell-identity genes and functions, including the IL-22/26 locus in ILC3s.
RESULTS

Transcriptome Profiling of Human ILC and Th Cells
To interrogate unique and overlapping pathways in ILC and Th cells from a mucosal environment, we isolated lymphocytes from pediatric tonsils. This source provides a sufficient number of purified ILCs for transcriptome and low-input epigenome analyses. We divided lineage-negative cells that expressed CD56 and NKp44 into CD103 + iILC1s and CCR6 + ILC3s ( Figure 1A ).
The latter subset produces IL-22 in response to IL-23, confirming its functional categorization (Cella et al., 2010) . CD4-enriched tonsillar lymphocytes were divided into CXCR3 + Th1 and CCR6 + Th17 cells, as previously described (Annunziato et al., 2007; Zielinski et al., 2012) . ILC2 and Th2 subsets were in sparingly low abundance in tonsils and could not be analyzed. As a comparator for ILCs, we isolated the prototypic innate lymphoid subset, cNK cells (CD56 low NKp44 -), from human blood. To explore relationships between cell types, we performed supervised principal components analysis (PCA) on expression array data, focusing on the top 15% most differentially expressed genes. A reproducible separation was observed between ILC3, ILC1, cNK, and Th cells ( Figure 1B) . Consistent with prior studies (Cosmi et al., 2008; Ramesh et al., 2014) , gene expression in Th1 and Th17 replicates from different tonsils was highly related, with a single module of genes providing a primary distinction (PC3). PCA clearly segregated innate cells from their Th functional counterparts; i.e., iILC1s were distinct from Th1s, and ILC3s were distinct from Th17s. Thus, ILC and T lineage commitment dominated functional relationships in several transcriptional modules. PCA also revealed that blood cNKs substantially segregated from their functional counterpart, iILC1s. When comparisons were broadened to entire transcriptomes, unsupervised hierarchical clustering of array data separated all tonsillar subsets from blood cNKs ( Figure S1A ). These analyses suggested that the mucosal microenvironment, in addition to lineage specification, had an influence on expression programs in lymphoid cells. Indeed, differentially expressed genes in iILC1s, when compared with blood cNKs, generated a signature that was present in all four tonsillar subsets (Figures S1B and S1C). As such, we restricted most comparisons to cells derived from tonsils, using blood cNKs as external comparators.
Although PCA underscored distinctions in transcriptional modules between innate and adaptive counterparts, ILC and Th subsets share overlapping developmental pathways and functions. Therefore, we asked which genes were uniquely (C) Plot comparing the fold change of ILC3 and iILC1 to the fold change of Th17 and Th1 depicts transcripts differentially expressed among ILCs and Th subsets. Colored circles highlight transcripts expressed at least 2-fold higher in a single tonsillar subset compared with the other three subsets. Colored circles with black borders denote transcripts that are shared by both an ILC and Th subset with expression >2-fold higher than cells of their respective lineage. overexpressed by each subset and which were shared by multiple subsets. Comparisons of fold change expression profiles revealed important features of lineage specification and functional polarization. First, ''unique'' transcripts were most abundant in ILC3s (100), followed by iILC1s, Th17s, and Th1s ( Figure 1C) . Second, the number of ''unique'' transcripts was far greater than that shared between any ILC and any Th subset. Third, among the latter transcript category, ILC3+Th17 was dominant (19 transcripts). These data suggested that, despite similar functionality, ILC and Th counterparts have fundamentally distinct transcriptional programs. Indeed, ILCs shared more differentially expressed genes with each other (118) than with their Th counterparts (27) and vice versa (123) (Figures 1C and 1D ). These data suggest that ILC and T lineage factors distinguish between the identity of cytokine-producing lymphocytes to a greater extent than do factors governing their functional polarization.
In this regard, Figure 1E highlights a set of genes whose expression distinguished between innate and adaptive subsets, spotlighting six biological categories. Importantly, genes encoding lineage determinants, receptors, and effector molecules aligned with the predicted functionality of each subset. For example, expression of RORC, CCR6, and IL26 was shared between ILC3s and Th17s, whereas CXCR3 and IFNG were shared between iILC1s and Th1s. Although TBX21, a ''master'' TF for Th1/ILC1 lineages, was expressed 2-fold higher in iILC1 than in ILC3 cells, the probe set had low absolute values and fell below the cutoff criteria. In addition, T-cell markers, such as CD4 and CD28, were expressed by Th1 and Th17 cells, while many NK cell markers, such as KLRK1, KLRC1, NCR1, and CRTAM, were expressed by iILC1s and ILC3s.
Several features of this analysis should be emphasized. First, consistent with patterns of ''unique'' genes, ILC3s expressed a substantial number of ''unique'' TFs. These included not only known ILC3 factors (RORC and AHR) but also several whose roles in ILC3 biology were less clear (e.g., RUNX2, BACH2, and ZBTB34). Second, consistent with their primary activation modes (cytokines for ILCs and antigen for T cells), ILCs expressed more cytokine receptors at substantially higher levels than did Th cells, with a notable exception. Both Th subsets specifically expressed IL6R and IL6ST, which form the IL6 receptor, suggesting that this proinflammatory cytokine may regulate Th, but not ILC, responses. Third, when compared with Th subsets, ILCs expressed a distinct set of metabolic genes, particularly those encoding enzymes with anti-microbial functions (e.g., AOAH, BLVRA, and FUCA1).
Next, we performed ingenuity pathway analysis (IPA) on genes with greater than 2-fold differences in ILC3s versus Th17s, iILC1s versus Th1s, or ILC3s versus iILC1s (Figures S1D-S1F). These analyses indicated that Th-enriched genes connected to pathways for TCR signaling, and ILC-enriched genes coordinated pathways for cytokine signaling or attenuated TCR signaling (e.g., cyclosporin A in the IPA database). Pathway distinctions were more apparent when input transcripts were restricted to those differentially expressed by both ILC subsets compared to both Th subsets, generating a network composed almost entirely of signaling molecules ( Figure 1F ). Differentially expressed transcripts created an innate activation module for ILCs centered on FCER1G (FcRg) and TYROBP (DAP12), while the Th module centered on CD3 components. Despite distinct receptor origins, both pathways converged on the MAP kinase ERK.
Distinct pathways also emerged when individual ILC-Th subsets were compared. Pathways augmented in ILC3s versus Th17s were connected to ETS family TFs (designated SPI1 by the IPA database), which are known to regulate cNK cell development (Ramirez et al., 2012 ) (see Figure 3) or the IL1b cytokine ( Figure S1D ). The known potential of human ILC3s to convert into ILC1s also became evident. Namely, IL15-and T-BET-regulated pathways emerged when ILC3s were compared with Th cells, albeit these pathways had a lower Z score than did ILC3-iILC1 comparisons ( Figures S1D-S1F ). Together, transcriptome arrays confirmed and revealed modules of gene expression that coordinate lineage specification, signal transduction, and functional polarization of human ILC/Th subsets in a mucosal microenvironment.
ILC-Th Regulomes
Gene expression programs in ILC and Th subsets likely reflect distinct patterns of enhancer activation that, in turn, correspond to differences in TF profiles. Even genes that are co-expressed in ILC and Th subsets may be regulated by different sets of enhancers responding to distinct environmental cues (e.g., cytokines in ILCs and TCR ligation in Th cells). To probe the regulatory logic that specifies ILC/Th lineages and their functions, we performed regulome analysis using methods for ultra-low input chromatin profiling. We first identified regions of open chromatin, which demarcated active and poised regulatory elements, using an assay for transposase-accessible chromatin followed by high-throughput sequencing (ATAC-seq) (Buenrostro et al., 2013) . For Th1 cells, we used published DNase-seq data to identify accessible chromatin (GSM1024749). The activation status of each element was assessed using chromatin immunoprecipitation sequencing (ChIP-seq) for two histone modifications enriched at active promoters (H3K4me3) or enhancers (H3K27ac). To exclude architectural elements, most of which were ATAC + , known CTCF binding regions were removed from our master list of regulatory regions .
We focused epigenome analyses on enhancers, which generally are dominant regulatory elements for determining the expression status of target genes. Enhancers were defined as accessible chromatin regions that were >2 kb from known transcriptional start sites (TSSs) and were considered active if they coincided with H3K27ac peaks. These analyses revealed 140,000 enhancers that were active in at least one of the five cell types profiled (Figure 2A) , namely, tonsillar iILC1s, ILC3s, Th1s, Th17s, and blood cNKs. We also defined the regulatory circuitry of each cell type by linking enhancers to their putative target gene(s) (Table S1) using pattern recognition algorithms to assign concordant changes in chromatin and expression for genes within 250 kb of each enhancer .
Only 5% of identified enhancers were uniquely active in a single cell type. The majority of cell-type-specific enhancers were found in ILC3s, further underscoring their distinctive identity at both gene expression and regulome levels ( Figure 2A) . Expression of genes located most proximally to cell-type-specific enhancers was augmented when compared with average expression in the other cell types ( Figures 2B and S2A ). Some enhancers were active in two cell types (10%). Consistent with gene expression patterns, the majority of these enhancers were shared by Th1/Th17 cells, followed by iILC1/ILC3 and ILC3/Th17 cells (Figure 2A ). Thus, a larger proportion of the regulome used by each subset was independent of its functional polarization. Instead, enhancer activation patterns were dominated by factors that coordinated divergence between Th and ILC lineages.
Next, we assessed whether enhancers active in only one subset were either off (DNase/ATAC -H3K27ac -) or poised (DNase/ ATAC + H3K27ac -) in other cell types. Figures 2C and S2B highlight examples of different enhancer categories for the IFNG and ZEB2 loci, respectively. As expected, the average expression of genes associated with poised enhancers was significantly lower than those near active enhancers ( Figure S2C ). A subset of enhancers uniquely active in a single cell type was poised in at least one other cell type ( Figure 2D ), especially for Th17s. This pattern suggests that each lineage retains some remnants of regulomes from an earlier common precursor, and/or they retain some degree of functional plasticity. Together, enhancer profiling defined the gene regulatory circuitry for ILC-Th cells, revealing a complex blend of elements that tracked cleanly with lineage specification or remained poised in a manner that reflected functional or developmental kinships.
Distinct TFs Dominate ILC and Th Regulomes TF expression is a critical determinant of enhancer activation during lineage specification or cellular activation. Many lineage decisions or biological responses are dominated by a single TF or related family. To more completely understand the TFs coordinating ILC and Th regulomes, we analyzed enhancer categories for enrichment of sequence motifs using HOMER. When analyses focused on innate versus adaptive lineages, enhancers with augmented H3K27ac levels in Th cells were enriched for motifs bound by BATF/AP1, IRF, NFAT, and EGR ( Figure 3A) , TFs activated by TCR signaling (Glasmacher et al., 2012; Li et al., 2012) . In contrast, enhancers hyperactive in both ILC See also Figure S2 and Tables S1, S2 , and S3.
subsets were enriched for RUNX and ETS motifs. Consistent with this finding, RUNX3 is essential for ILC development in mouse (Ebihara et al., 2015) . These new data also predict that an ETS family member is required for development, homeostasis, or function of ILC subsets. Next, we focused on enhancers that were augmented in a single cell type versus the other three. A full account of enriched TF motifs for cell-type-specific enhancers is provided in Table S2 . ''Master'' TFs for differentiation into functionally distinct subsets were enriched in the predicted lineages. A motif recognized by RORgT was enriched in ILC3-and Th17-specific enhancers, whereas enhancers unique to iILC1 and Th1 cells were enriched for a T-box motif, to which T-BET binds ( Figure 3B ). In addition to the distinctions described above for shared enhancers, motifs for PRDM1 were enriched in iILC1-and Th1-specific enhancers, perhaps indicating a role for PRDM1, or related TFs, in type 1 effector functions. Indeed, iILC1s expressed high levels of ZNF683 ( Figure 1E ), a PRDM1 homolog that is necessary and sufficient for IFN-g production in human CD8 + effector-type cells (Vieira Braga et al., 2015) . Th subsets were also enriched for HMG/TCF motifs, which are targets of TCF7, a TF essential for T cell development and function (Weber et al., 2011) . Consistent with results from this unbiased analysis, members of TF families enriched in cell-type-specific enhancers exhibited parallel expression patterns (Figures 3C and S3A ). Of note was the reciprocal expression pattern for two AP1 family members, BATF and FOSL2, which function as a transcriptional activator or repressor, respectively . Accordingly, the AP1 motif was enriched in active Th enhancers, where the activating factor BATF was expressed, while the repressive FOSL2 predominated in ILCs.
To validate some predictions, we leveraged public ChIP-seq data for human BATF and IRF4, whose motifs were enriched in Th-specific enhancers. Although ChIP-seq data were derived (E) UCSC Genome Browser view of human IL22 (top) as described in Figure 2C . The cell-type specificity of each boxed enhancer is shown at the top. The middle tracks denote sites of TF binding in GM12878 cells. The bottom tracks show data for BATF and IRF4 in mouse Th17 cells (Li et al., 2012) at conserved enhancer regions. See also Figure S3 .
from a transformed human B cell (GM12878), these TFs were bound at a higher percentage of Th17-specific compared with ILC3-specific enhancers ( Figure 3D ). Indeed, many Th17-specific enhancers bound both BATF and IRF4, likely reflecting the importance of composite sites for their stable association at some enhancers (Glasmacher et al., 2012; Li et al., 2012) . We also examined BATF and IRF4 binding at elements that exhibited preferential activity in given cell types ( Figures 3E and S3B ). For example, enhancers positioned near the IL22 cytokine gene, expressed by ILC3s and Th17s, displayed a range of cell-type specificity. However, two enhancers preferentially activated in Th17 cells were bound by BATF and IRF4, while an enhancer with higher activity in ILC3s was associated with SPI1 in the GM12878 B cells ( Figure 3E ). The two enhancers with augmented activity in Th17s were conserved in mouse and were bound by BATF and IRF4 in mouse Th17 cells. Thus, epigenome analyses identified a cohort of TFs that coordinate enhancer activation to regulate distinct gene expression programs in innate and adaptive lymphoid effectors from human mucosal tissue.
Human ILC and Th Super-Enhancers
Super-enhancers (SEs) encompass a class of regulatory elements devoted to maintaining high expression levels for genes associated with cell identity (Whyte et al., 2013) . SEs are distinguished by their extreme loads and broad distributions of H3K27ac, as well as their dramatic enrichment for lineage-specifying TFs. To further define genes that contribute to unique identities of ILC and Th cells in human, we used published algorithms and standard cutoff criteria to generate lists of SE regions from H3K27ac data (Table S3 ) . Ranked plots of H3K27ac + regions, which represent both super-enhancers and conventional enhancers (CE), are shown in Figure 4A , with celltype-specific SEs highlighted in red.
Consistent with their role in cell identity, many SEs (>30%; Figure 4B) were cell-type-specific, which is in contrast to our analyses of CEs (5% unique; Figure 2A ). However, like our findings with CEs, ILC3s had the most unique SEs, further confirming their striking distinction from the other cell types, while iILC1s and Th1s had the fewest unique SEs. As an example, an ILC3-specific SE encompassed the KIT receptor locus (Figure S4A) , which was selectively expressed in this cell type.
One of the few iILC1-specific SEs spanned AOAH ( Figure S4B ), which encodes an enzyme known to detoxify bacterial lipopolysaccharide (Munford and Hunter, 1992) , revealing an anti-microbial function for this innate mucosal subset. A cNK-specific SE was associated with the perforin (PRF1) gene. This SE was absent in iILC1s ( Figure S4C ), consistent with the cytolytic capacities of these two type 1 innate subsets. SEs shared in two cell types were most evident in Th1-Th17, a finding that also emerged from CE analysis. Two Th-shared SEs spanned the TNFSF8 ( Figure S4D ) and TNFRSF8 loci, reflecting the Th-specific expression of both CD30 and its ligand, respectively, which form an autoregulatory loop in activated T cells. A more general analysis revealed that genes encompassed by or flanking (±20 kb) a cell-type-specific SE exhibited significantly elevated expression in that cell lineage compared with the others ( Figure 4C) . A comparison of SEs in Th17s, ILC3s, and iILC1s identified 277 gene loci with important functions in both innate and lymphoid lineages, including CD69, which mediates tissue residency ( Figure 4D ) (Shiow et al., 2006) . 132 genes were encompassed by SEs active in ILC3s and Th17s, including several TFs (AHR and RORC) that play a role in differentiation of IL22-producing cells, and TOX2, whose role in these functional subsets was unclear. SE-associated genes shared by iILC1s and ILC3s encoded ZBTB16, a TF important for ILC lineage commitment (Ishizuka et al., 2016) , as well as the XCL chemokines (Figure S4E) , whose roles in ILC biology were unknown. Similar comparisons of Th-versus ILC-restricted SEs illuminated additional features of regulatory circuits that contrast Th and ILC identities ( Figure S4F ). We cannot exclude the possibility that some regions were called SEs in one cell type, but barely missed the SE cutoff in one or more of the other cell types; this can be discerned from focused inspections of the primary data. Notwithstanding, our identification of SEs in human lymphoid cells highlights unique and shared epigenetic landscapes that endow ILCs with aspects of cell identity distinguishing them from their Th and NK counterparts.
SEs Associated with Signature Cytokines and Surface Markers
In addition to expected loci, SE analysis uncovered relationships that may provide new insights or tools for studying ILC biology. One example was the CD300LF locus, which encodes a phospholipid-responsive inhibitory receptor (Choi et al., 2011) , and was spanned by an ILC3-specific SE ( Figure 5A ). Accordingly, CD300LF mRNA was expressed at a significantly higher level by ILC3s, and the protein was detected on their cell surface (Figures 5A and 5B), further defining the distinct phenotype of this innate subset.
We also identified an SE in Th17 cells that spanned its signature IL17A/IL17F cytokine locus, as well as the neighboring MCM3 gene, which is expressed in all cell types ( Figure 5C ). In contrast to mice, which express Il17 in both Th17s and a subset of ILC3s, humans express these cytokines only in Th17s (Figure 1E) . Only a subset of enhancers active in Th17s were in regions of high sequence conservation, perhaps reflecting evolutionary revisions to the regulatory landscape of this locus that endow Th17-specific expression in humans. Indeed, the vast majority of active IL17A/F enhancers were completely off in ILC3s, with the exception of several that remained poised, suggesting a minimal potential for activation-induced IL-17 expression by agonists. Future studies should allow the identification of CEs within SEs that mediate divergent IL17 expression patterns in mouse and human. In human, the signature ILC3 cytokine locus spans IL22 and IL26, which lie between the ubiquitously expressed MDM1 gene and the Th1/iILC1-restricted cytokine gene IFNG (Figure 5D) . Regulation of the latter gene has been extensively studied in both mouse and human (Ansel et al., 2003; Balasubramani et al., 2010; Collins et al., 2012) ; however, much less is known about the cis-elements controlling IL22/26. Strikingly, we identified an ILC3-specific SE distal to MDM1, which precisely paralleled expression of IL22 ( Figure 1E ). In contrast to the composite SE element, many individual CEs in this region, including some within the SE, were shared with other cell types. The most related H3K27ac landscape was in Th17s, potentially explaining their expression of IL26 ( Figure 1E ). We predicted that the SE and its composite CEs were critical elements regulating celltype-restricted expression of IL22/26. Indeed, a CE with the most intense deposition of H3K27ac (SE-112), which was conserved in mammals, exhibited robust enhancer activity in a human T cell, but not in a hepatoma cell line ( Figure 5E ). A second region (SE-104), which was less conserved and had lower levels of H3K27ac, was inert in both cell types. We also measured cross-linking efficiencies of the IL22 promoter with SE elements using chromosome conformation capture (3C), which provided a readout for the association between the promoter and selected distal regions. As shown in Figure 5F , the IL22 promoter efficiently associated with two conserved CEs, including SE-112, compared with two regions outside of the SE, which lacked active enhancers. One element, termed IL22-198, exhibited significantly higher cross-linking in cultured Th17 versus Th1 cells, reflecting higher IL22 expression in the former. However, this region did not function as an enhancer in Jurkat T cells, perhaps due to the lack of Th17 polarization in this transformed line. Thus, a novel regulatory region, including an ILC3-specific SE, controlled the expression of IL22 and IL26 in both innate and adaptive lymphoid cells inhabiting human mucosae.
ILC Super-Enhancers Are Enriched for AutoimmuneAssociated SNPs
Most disease-associated differences in human genomes colocalize with regulatory elements rather than with coding exons (Maurano et al., 2012) . These elements include SEs, which control the cohort of genes for cell identity and their signature functions. For ILC and Th cells, obvious signature functions include secretion of pro-inflammatory mediators (e.g., IL-17 and IFN-g), dysregulation of which leads to a spectrum of autoimmune conditions. We investigated whether SEs for lymphoid cells were enriched for SNPs linked to autoimmunity by GWAS. As shown in Figure 6A , 20% of reported autoimmune SNPs were encompassed by an SE identified in any ILC-Th subset. In contrast, a significantly lower proportion of SNPs for non-B cell cancers were found in this SE collection (5%).
When categorized by cell-type distributions, Th17-and ILC3-specific SEs had the most autoimmune SNPs, followed by shared SEs found in either Th1-Th17 or ILC3-Th17 cells (Figure 6B) . Next, we compared the gene content of SNP-associated SEs for four disorders: Crohn's disease (CD), ulcerative colitis (UC), rheumatoid arthritis (RA), and type 1 diabetes (T1D). SNPs associated with CD and UC were primarily restricted to ILC3 and Th17 SEs (Table 1) . A subset of these disease-associated SNPs was localized to SEs regulating genes implicated in autoimmunity, including IL23R (ILC3-specific) and STAT3 (ILC3+Th17). Our analyses also identified loci harboring genes with ILC-specific SEs that were linked to autoimmunity by their functions in other cell types. One example, ATG16L1, had been linked to autoimmunity via its expression in Paneth and dendritic cells (Stappenbeck et al., 2011) . In contrast to UC and CD, SNPs identified for RA and T1D were enriched in Th1-Th17 SEs. Many genes linked to these SNP-containing SEs have been implicated in RA or T1D, including IL2RA/B, CTLA4, and CSF2 (Marson et al., 2015) . One mechanism by which SNPs contribute to pathogenesis is alteration of TF sites in key enhancers. Indeed, 80% of autoimmune SNPs in the ILC-Th SEs were predicted to disrupt motifs for known TFs, two examples of which are provided in Figure 6C . The first highlights a UC-associated SNP found in an ILC3-specific SE spanning IL1R1, in which the polymorphic allele was predicted to disrupt an ETS site, a motif enriched in ILC-specific enhancers ( Figure 3A) . The second example was in an ILC+Th SE that spanned the ASAP1 gene for an ARF-GAP signaling mediator. The MS-associated SNP was predicted to disrupt a STAT1 motif, a TF expressed in most cells ( Figure 3C ). We conclude that SEs spanning ILC-Th identity genes are enriched for autoimmune SNPs, perhaps reflecting the ''TF motif breaking'' consequences of nucleotide diversity in humans.
DISCUSSION
The importance of ILCs in mammalian immunity has emerged from in vitro studies in human and functional analyses in mice. However, many outstanding questions remain, especially with regard to ontogeny, functional relationships, ILC plasticity, and species distinctions. By integrating transcriptome and epigenome platforms, we shed light on important facets of lineage and functional relationships between innate and adaptive Th counterparts derived from a human mucosal tissue. These analyses defined human ILC-Th gene expression programs and corresponding gene regulatory schematics, revealing important aspects of their developmental and functional relationships.
Key findings to emerge included (1) human ILC3s exhibited the most distinctive signatures of gene expression and active regulomes compared with other ILC-Th cells, (2) human iILC1s diverged as a unique lineage from cNK cells, (3) Th and ILC regulomes defined gene circuitry nodes that associated with lineage bifurcation (shared in Th1-17 versus shared in ILC1-3), which were often distinct from circuitry nodes shared for functional polarization (Th17-ILC3 versus Th1-iILC1), (4) coordinately regulated enhancers identified TF families that governed Th versus ILC regulomes, (5) SE patterns defined cell identity genes and regulatory regions for known functional mediators, and (6) SEs spanning ILC-Th identity genes were enriched for autoimmune SNPs, perhaps revealing critical regulatory elements for differential gene expression in these diseases.
Lineage relationships between human ILC and cNK cells have been a subject of intense debate. Reports have provided evidence that tonsillar ILC3s develop from a lineage-restricted progenitor (Montaldo et al., 2014) (Hughes et al., 2014) . Transcriptome, regulome, and SE profiles demonstrated that ILC3s were the most divergent of the innate and adaptive cell types examined, including when compared with cNK or Th17, their closest functional counterparts. However, (Constantinides et al., 2014 (Constantinides et al., , 2015 . In contrast, independent data supported a model in which ILC1s were tissue-resident cNK cells (Sojka et al., 2014) . While our study cannot completely resolve this issue, expression programs and regulomes of iILC1s significantly diverged from blood cNKs. Such divergence in gene circuitry renders it unlikely that iLC1s and cNKs are the same cell type. Notwithstanding, microenvironmental factors, layered on top of lineage specification, may contribute to this divergent regulatory logic. In-depth study of this issue will require extensive phenotypic characterization of the multiple IFN-g-producing cells that inhabit human mucosae.
Regulome analyses indicated that the identity of each lymphoid subset was sculpted from distinct and shared gene circuitry modules that imparted developmental kinship (Th versus ILC) or signature functionalities (Th17-ILC3 versus ILC1-Th1-cNK). The adaptive modules included circuitry for genes involved in TCR signaling, and switches for these circuits were a cohort of enhancers targeted by TFs linked to TCR signaling, such as BATF and IRF4 (Glasmacher et al., 2012; Li et al., 2012) . Innate modules were enriched for circuitry governed by signals from innate immune receptors, including those associated with FCER1G and TYROBP adaptors. Like TCR signaling, these receptor-driven pathways converged on MAP kinases (e.g., ERK), but connected to distinct TFs. Enhancers linked to circuits in the innate module were enriched for RUNX-ETS composite sites rather than for AP1-IRF composite elements found in Th enhancers. Of note, RUNX3 is essential for ILC1 and ILC3 development in mouse (Ebihara et al., 2015) , but a requirement for ETS TFs in the ILC lineage remains unknown.
An important regulome stratum is the establishment of SEs that drive expression of genes for lineage identity and signature cell functions. Indeed, ILC-Th cells harbored a higher proportion of SEs unique to one cell type when compared with CEs, which were normally shared between two or more lineages. Cell-typespecific SEs were linked to a number of ''cell-identity'' genes whose functions in ILC biology were not recognized, including CD300L, AOAH, TNSF13B (BAFF), LIF, and TOX2. Notably, several of these genes were expressed in human, but not in mouse, ILC subsets (Robinette et al., 2015) . Thus, our study highlights shared and divergent features of ILCs from different species and provides a rich resource for more in-depth functional analyses. For example, functional dissection of an SE near the IL22-IL26-IFNG locus would be an important goal. If the SE or its composite elements were conserved in mouse, its spatial segregation from genes permits targeted deletion. Similarly, comparison of the SE spanning IL17A/F genes, which is only active in human Th17s, with syntenic regions in mice, where these genes are expressed in both ILC3 and Th17 cells, may reveal differences in the activities of individual enhancers that mediate innate versus adaptive expression patterns of the inflammatory cytokines IL17A/F. Many SEs shared in Th-ILC lineages likely rely on a combination of elements, which have shared or cell-type-restricted activities. Dissection of such regulatory circuits will identify key enhancers that govern iILC1, ILC3, Th17, and Th1 cell identities.
EXPERIMENTAL PROCEDURES
Details for the ATAC-seq, ChIP-seq, and informatics analysis are in the Supplemental Experimental Procedures.
Cytometric and Microarray Analyses
Cells were sorted from 2-3 pooled donors for each replicate as previously described (Annunziato et al., 2007; Cella et al., 2010; Fuchs et al., 2013) . RNA was isolated (RNeasy Plus Micro Kit, QIAGEN), amplified, and hybridized to the Affymetrix Human Gene (v.1.0) ST arrays. RNA yields from each subset were comparable. Array data were analyzed as previously described (Robinette et al., 2015) . Unsupervised clustering was performed in R using the hclust function. For CD300LF analyses, CD56-enriched tonsil cells were stained with a PercP-Cy5.5 lineage cocktail containing anti-CD3 (eBioscience), anti-CD19 (eBioscience), anti-CD34 (Biolegend), and anti-ILT3 (Biolegend). Cells were stained with the following combination of antibodies (Biolegend, unless indicated): CD117-FITC, NKp44-PE (BD-PharMingen), CD300f-eFluor660 (eBioscience), CD196-BV421, CD103-BV605, CD161-BV510, CD56-PE-Cy7 (BD-PharMingen), and CD127-biotin (eBioscience), followed by Streptavidin-APC-eFluor780. Data were acquired on an LSR-Fortessa (BD) and analyzed by FlowJo software (TreeStar). Tonsils and peripheral blood were obtained under approval of the WUSM institutional review board.
ATAC-and ChIP-Seq ATAC sample preparation was carried out as described (Buenrostro et al., 2013) . Libraries for 2-3 samples were pooled for PE50 sequencing (Illumina HiSeq2500). Inter-sample variability was minimal for datasets from a given cell type (r 2 > 0.92). ATAC data for tonsillar Th17s recapitulated those published for their blood counterparts (>90% peaks; GEO: GSE29692). Ultralow input ChIP-seq was carried out as previously described (Brind'Amour et al., 2015) .
Luciferase SE regions were PCR amplified and cloned into SV40 promoter-driven PGL3 plasmid (Promega). Reporters were transfected into Jurkat cells by electroporation or HepG2 cells using Lipofectamine 2000 (InVitrogen).
Chromatin Conformation Capture 3C was performed on BglII-digested chromatin from primary Th1 and 17 cells (10 7 ) as previously described (Majumder et al., 2015) and assayed using primer/probe combinations provided in the Supplemental Experimental Procedures. Standard curves were prepared from BglII-digested bacterial artificial chromosomes spanning the IL22 locus, and interactions between neighboring fragments within YWHAZ were used for normalization.
ACCESSION NUMBERS
The accession numbers for the data reported in this paper have been uploaded to GEO with the accession numbers GEO: GSE77299 and GSE78897. 
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